Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
The Journal of Allergy and Clinical Immunology|March 15, 2016
Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related diseaseHamid Mattoo, Vinay S Mahajan, Takashi Maehara, et al.
European Journal of Internal Medicine|June 3, 2020
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort studyCorrado Campochiaro, Emanuel Della-Torre, Giulio Cavalli, et al.
Cancers|September 28, 2021
Efficacy of Endoscopic Ultrasound-Guided Ablation with the HybridTherm Probe in Locally Advanced or Borderline Resectable Pancreatic Cancer: A Phase II Randomized Controlled TrialSabrina Gloria Giulia Testoni, Maria Chiara Petrone, Michele Reni, et al.
Annals of the Rheumatic Diseases|July 21, 2026
A phase 2 trial of rilzabrutinib in IgG4-related diseaseJohn H Stone, Mollie Carruthers, Matthew C Baker, et al.
Endoscopy International Open|October 12, 2020
Necrosis volume and Choi criteria predict the response to endoscopic ultrasonography-guided HybridTherm ablation of locally advanced pancreatic cancerSabrina Gloria Giulia Testoni, Gabriele Capurso, Maria Chiara Petrone, et al.
Rheumatology (Oxford, England)|October 5, 2017
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related diseaseAlvise Berti, Emanuel Della-Torre, Francesca Gallivanone, et al.
Microvascular Research|September 19, 2020
Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvementGerlando Natalello, Giacomo De Luca, Laura Gigante, et al.
European Journal of Internal Medicine|August 19, 2025
Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study of 115 patientsElisabetta Goni, Jens Vikse, Marco Lanzillotta, et al.
Oncoimmunology|September 14, 2020
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinomaClaudia Minici, Elena Rigamonti, Marco Lanzillotta, et al.
European Journal of Internal Medicine|March 20, 2026
Rituximab limits glucocorticoid use in IgG4-related disease: Real-world evidence from a large European cohortJens Vikse, Marco Lanzillotta, Elisabetta Goni, et al.
Pageof 10